A5074192126- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Global Cancer Incidence and Screening
- Genital Health and Disease
- Endometrial and Cervical Cancer Treatments
- Reproductive tract infections research
- Vaccine Coverage and Hesitancy
- Colorectal Cancer Screening and Detection
- Liver Disease Diagnosis and Treatment
- Reproductive Health and Contraception
- Molecular Biology Techniques and Applications
- Adolescent Sexual and Reproductive Health
- Genetic factors in colorectal cancer
- Cancer Risks and Factors
- Advanced Multi-Objective Optimization Algorithms
- Hepatitis C virus research
- Clinical practice guidelines implementation
- Cardiac, Anesthesia and Surgical Outcomes
- Intimate Partner and Family Violence
- Economic and Financial Impacts of Cancer
- Pancreatic and Hepatic Oncology Research
- Reproductive System and Pregnancy
- Cancer Genomics and Diagnostics
- Simulation Techniques and Applications
- Female Genital Mutilation/Cutting Issues
Institut Català d'Oncologia
2013-2023
Institut d'Investigació Biomédica de Bellvitge
2012-2023
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2021-2023
Centro de Investigación Biomédica en Red de Cáncer
2018-2019
GTx (United States)
2015
Lancet Laboratories
2012
Decision Sciences (United States)
2011
Universitat Autònoma de Barcelona
2008
Institut Català d'Ornitologia
2008
Health Canada
2006
Abstract At least 15 types of HPV have been associated with cervical cancer, but current vaccines confer only type‐specific immunity. To determine geographic variations in the type distribution we carried out a pooled analysis data from an international survey cancer and multicenter case‐control study, both co‐coordinated by IARC. Study cases were 3,607 women incident, histologically confirmed recruited 25 countries. DNA detection typing cells or biopsies centrally done using PCR assays....
Since 2006, many countries have implemented publicly funded human papillomavirus (HPV) immunisation programmes. However, global estimates of the extent and impact vaccine coverage are still unavailable. We aimed to quantify worldwide cumulative HPV programmes up 2014, potential on future cervical cancer cases deaths.
Early age at first sexual intercourse (AFSI) has long been associated with an increased risk of invasive cervical carcinoma (ICC). Age pregnancy (AFP) and ICC have investigated less, although AFSI AFP are strongly interrelated in most developing countries. A pooled analysis case–control studies on from eight countries 1864 cases 1719 controls the roles AFSI, AFP, risk. intercourse, marriage (AFM) were highly had similar estimates. Compared women ⩾21 years, odds ratio (OR) was 1.80 (95% CI:...
Background Cervical cancer is the most common in women Mali and second commonest cause of mortality.
In Brief Background and Objective Human papillomavirus (HPV) is a major cause of invasive cervical cancer. Identification HPV determinants might allow for targeting high-risk groups Goal The goal was to estimate the prevalence its among women from general population Barcelona. Study Design We studied random sample female residents in metropolitan Barcelona, Spain (n = 973). Information obtained through personal interviews laboratory testing exfoliated cells. detected using GP5+/6+ polymerase...
Cervical cancer is a leading cause of death among women in low-income countries, with ∼25% cases worldwide occurring India. We estimated the potential health and economic impact different cervical prevention strategies. After empirically calibrating model to country-specific epidemiologic data, we projected incidence, life expectancy, lifetime costs (I$2005), calculated incremental cost-effectiveness ratios (I$/YLS) for following strategies: pre-adolescent vaccination girls before age 12,...
Abstract Eastern Africa has the world's highest cervical cancer incidence and mortality rates. We used epidemiologic data from Kenya, Mozambique, Tanzania, Uganda, Zimbabwe to develop models of HPV‐related infection disease. For each country, we assessed HPV vaccination girls before age 12 followed by screening with DNA testing once, twice, or three times per lifetime (at ages 35, 40, 45). women over 30, only (with up VIA at 35). Assuming no waning immunity, mean reduction in risk associated...
Approximately 70% of cases cervical cancer worldwide are caused by genotypes 16 and 18 human papillomavirus (HPV), which is sexually transmitted. With the availability an effective vaccine against these HPV types, there real hope for reducing global burden in developing countries. Stakeholders faced with decisions about where to invest money improve health must consider disease relative other priorities comparative benefits different interventions. We conducted a series analyses obtain...
Male circumcision has been shown to reduce the risk of acquiring and transmitting a number venereal infections. However, little is known about association between male Chlamydia trachomatis infection in female partner. The authors pooled data on 305 adult couples enrolled as controls one five case-control studies invasive cervical cancer conducted Thailand, Philippines, Brazil, Colombia, Spain 1985 1997. Women provided blood samples for C. pneumoniae antibody detection; type-specific...